Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous CAR-engineered regulatory T cells SBT777101

A preparation of autologous T-regulatory cells (Tregs) that have been genetically modified to express a chimeric antigen receptor (CAR) targeting citrullinated proteins, with potential immunmodulating activity. Upon administration, the autologous CAR-engineered regulatory T cells SBT777101 target and bind to citrullinated proteins and may decrease inflammation and promote immunologic homeostasis. Citrullinated proteins are found in inflamed disease-associated tissues in many autoimmune and inflammatory diseases.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous CAR-engineered Treg cells SBT777101
autologous CAR-Treg cells SBT777101
autologous CAR-Tregs SBT-77-7101
Code name:SBT 77 7101
SBT-77-7101
SBT-777101
SBT77-7101
SBT777101
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search